Molecularly imprinted mesoporous silica (MIPMS) is one of the methods to improve site accessibility molecule target on molecularly imprinted polymer (MIP) for application in solid-phase extraction (SPE). The MIPMS was prepared using salbutamol sulfate as template molecule, cetyltrimethylammonium bromide as a directing agent, and tetraethyl orthosilicate and methyltriethoxysilane were used as silica precursor and organosilane. In this study, two TEOS : MTES ratios were used. The MIPMS-2 with 3 : 1 ratio of TEOS : MTES has better analytical performance than the MIPMS-1 with 2 : 1 ratio of TEOS : MTES. The adsorption capacity of MIPMS-2 was about 0.0934 mg/g, and it was 0.0407 mg/g for NIPMS-2. The extraction ability of MIPMS-2 was good, with a recovery of about 104.79% ± 1.01% of salbutamol in spiked serum. The imprinting factor (IF) value obtained is 1.2. When serum was spiked with salbutamol and terbutaline, the ability of NIPMS-2 to recognize salbutamol increased. Therefore, optimizing the conditions for the MIPMS synthesis is necessary to produce a sorbent with better selectivity.